The effect of hormonal contraception on genital tract shedding of HIV-1

No abstract is available for this paper.

• Publication year

  2004

• Venue

  AIDS (London)

• Publication date

  2004-01-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00002030-200401230-00009PMID 15075537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validation of Performance of the Gen-Probe Human Immunodeficiency Virus Type 1 Viral Load Assay with Genital Swabs and Breast Milk Samples

  2002cited by this paper
• Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections.

  2001cited by this paper
• Determinants of HIV-1 shedding in the genital tract of women.

  2001cited by this paper
• The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1.

  2001cited by this paper
• Treatment of cervicitis is associated with decreased cervical shedding of HIV-1

  2001cited by this paper
• Oral contraceptives--an update.

  2000cited by this paper
• Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission.

  2000cited by this paper
• Risk of HIV infection in oral contraceptive pill users: a meta-analysis.

  1999cited by this paper
• HIV-1 RNA in plasma and genital tract secretions in women infected with HIV-1.

  1999cited by this paper
• Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.

  1997cited by this paper
• Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4 cell depletion.

  1995cited by this paper
• Maternal vitamin A deficiency and mother-to-child transmission of HIV-1.

  1994cited by this paper

• A practical clinical guide to counselling on and managing contraception, pre-conception planning, and menopause for women living with HIV.

  2021cites this paper
• Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission

  2019cites this paper
• HIV and SIV in Body Fluids: From Breast Milk to the Genitourinary Tract.

  2019cites this paper
• Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial☆☆☆★★★

  2018cites this paper
• MicroCOSM: a model of social and structural drivers of HIV and interventions to reduce HIV incidence in high-risk populations in South Africa

  2018cites this paper
• Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms

  2018cites this paper
• A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.

  2017cites this paper
• ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists

  2017cites this paper
• Contraception for HIV-Infected Adolescents

  2016cites this paper
• Immunology of the Female Reproductive Mucosa

  2016cites this paper
• Reproductive Tract Infections in Women

  2015cites this paper
• Medroxyprogesterone acetate increases HIV-1 infection of unstimulated peripheral blood mononuclear cells in vitro

  2015cites this paper
• Sex Differences in the Manifestations of HIV-1 Infection

  2015cites this paper
• 128 – Human Immunodeficiency Virus Infection in Women

  2015cites this paper
• HIV Reservoir Dynamics in the Face of Highly Active Antiretroviral Therapy

  2015cites this paper
• Differential effects of progestogens on HIV-1 replication and host gene expression in primary PBMCs and cervical tissue explants

  2015cites this paper
• Role of the glucocorticoid receptor and HIV-1 Vpr in inflammatory gene expression and HIV-1 LTR transcription in response to dexamethasone and progestogens

  2015cites this paper
• A Prospective Cohort Study of the Effect of Depot Medroxyprogesterone Acetate on Detection of Plasma and Cervical HIV-1 in Women Initiating and Continuing Antiretroviral Therapy

  2014cites this paper
• Presence of CD8+ T Cells in the Ectocervical Mucosa Correlates with Genital Viral Shedding in HIV-Infected Women despite a Low Prevalence of HIV RNA–Expressing Cells in the Tissue

  2014cites this paper
• Differential Glucocorticoid Receptor‐Mediated Effects on Immunomodulatory Gene Expression by Progestin Contraceptives: Implications for HIV‐1 Pathogenesis

  2014cites this paper
• The Injectable-Only Contraceptive Medroxyprogesterone Acetate, Unlike Norethisterone Acetate and Progesterone, Regulates Inflammatory Genes in Endocervical Cells via the Glucocorticoid Receptor

  2014cites this paper
• Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection

  2014cites this paper
• Immunology of Genital Tract Infections

  2014cites this paper
• Progesterone protects normative anxiety-like responding among ovariectomized female mice that conditionally express the HIV-1 regulatory protein, Tat, in the CNS.

  2014cites this paper
• Effect of hormonal contraceptive methods on HIV disease progression: a systematic review

  2013cites this paper
• Dendritic cells and vaccine design for sexually-transmitted diseases.

  2013cites this paper
• Place of assisted reproductive technologies in the realization of reproductive function in HIV-infected persons

  2013cites this paper
• The Contraceptive Depot Medroxyprogesterone Acetate Impairs Mycobacterial Control and Inhibits Cytokine Secretion in Mice Infected with Mycobacterium tuberculosis

  2013cites this paper
• A word of caution: do not wake sleeping dogs; micrometastases of melanoma suddenly grew after progesterone treatment

  2013cites this paper
• The Progestin-Only Contraceptive Medroxyprogesterone Acetate, but Not Norethisterone Acetate, Enhances HIV-1 Vpr-Mediated Apoptosis in Human CD4+ T Cells through the Glucocorticoid Receptor

  2013cites this paper
• Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms.

  2013cites this paper
• Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence

  2013cites this paper
• Modulation of GR transcriptional signalling by HIV-1 Vpr: insights into regulation by progestins

  2012cites this paper
• Reproductive Healthcare Needs and Desires in a Cohort of HIV-Positive Women

  2012cites this paper
• Dendritic Cell Activation and Memory Cell Development Are Impaired among Mice Administered Medroxyprogesterone Acetate Prior to Mucosal Herpes Simplex Virus Type 1 Infection

  2012cites this paper
• Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation

  2012cites this paper
• Infection Prior to Mucosal Herpes Simplex Virus Type Administered Medroxyprogesterone Acetate Development Are Impaired among Mice Dendritic Cell Activation and Memory Cell

  2012cites this paper
• 8. Progestin Injectables

  2011cites this paper
• Effect of menstrual cycle variation in female sex hormones on cellular immunity and regulation.

  2011cites this paper
• Hormonal Contraception and HIV‐1 Transmission

  2011cites this paper
• olecular mechanisms of steroid receptor-mediated actions by synthetic rogestins used in HRT and contraception

  2011cites this paper
• Correlates of HIV-1 Genital Shedding in Tanzanian Women

  2011cites this paper
• Increased prevalence of sexually transmitted viral infections in women: the role of female sex hormones in regulating susceptibility and immune responses.

  2011cites this paper
• Original research article Low-dose combined oral contraceptive and cervicovaginal shedding of human immunodeficiency virus

  2011cites this paper
• Low-dose combined oral contraceptive and cervicovaginal shedding of human immunodeficiency virus.

  2011cites this paper
• Quantifying sexual exposure to HIV within an HIV-serodiscordant relationship: development of an algorithm

  2011cites this paper
• Hormonal contraceptive use and response to antiretroviral therapy among adolescent females

  2011cites this paper
• Investigation of differential TNFα-induced interleukin-6 gene regulation by synthesis progestins medroxyprogesterone acetate (MPA) and norethindrone acetate (NET-A) in human endocervical epithelial cells and the role of the unliganded glucocorticoid receptor

  2010cites this paper
• Hormonal contraception for HIV positive women.

  2010cites this paper
• Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

  2010cites this paper
• Targeting Trojan Horse leukocytes for HIV prevention

  2010cites this paper
• Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load

  2010cites this paper
• Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection

  2010cites this paper
• Sexually Transmitted Infections in Men and Women

  2010cites this paper
• Sex Steroids and Risk of Female Genital Tract Infection

  2010cites this paper
• Comparative study of the molecular mechanism of action of the synthetic progestins, Medroxyprogesterone acetate and Norethisterone acetate

  2010cites this paper
• HIV transmission by HIV-infected women using hormonal contraception.

  2009cites this paper
• Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus Initiative

  2009cites this paper
• Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review

  2009influential citation
• Reproduction and fertility in human immunodeficiency virus type-1 infection

  2009cites this paper
• The Effect of Progesterone Levels and Pregnancy on HIV-1 Coreceptor Expression

  2009cites this paper
• The role of the local microenvironment in regulating susceptibility and immune responses to sexually transmitted viruses in the female genital tract.

  2009cites this paper
• Male reproduction and HIV-1 infection

  2009cites this paper
• The development and pilot evaluation of an interactive computer-based program to help young people's contraceptive decision making: MyWay

  2008cites this paper
• Is the use of hormonal contraception safe for women who smoke cigarettes ?

  2008cites this paper
• Carga viral vaginal de HIV em mulheres brasileiras infectadas pelo HIV

  2008cites this paper
• [HIV vaginal viral load in Brazilian HIV-infected women].

  2008cites this paper
• Contraception and HIV infection in women

  2008cites this paper
• Care of the Adolescent With HIV

  2008cites this paper
• Hormonal contraception and HIV disease progression.

  2008cites this paper
• Relationship between plasma selenium concentrations and lower genital tract levels of HIV-1 RNA and interleukin type 1beta.

  2007cites this paper
• Obstetric and Gynaecological Aspects of HIV infection in Finland

  2007cites this paper
• Lack of association between genital tract HIV-1 RNA shedding and hormonal contraceptive use in a cohort of Louisiana women.

  2007cites this paper
• Premenstrual Syndrome: An Evolutionary Perspective on Its Causes and Treatment

  2007cites this paper
• Study Design to Evaluate the Safety and Effectiveness of Hormonal Contraception for Women

  2007cites this paper
• Relationship between plasma selenium concentrations and lower genital tract levels of HIV-1 RNA and interleukin type 1β

  2007cites this paper
• Contraceptive counseling for adolescents with HIV.

  2007cites this paper
• Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women

  2007cites this paper
• HIV-1-discordant couples in sub-Saharan Africa: explanations and implications for high rates of discordancy.

  2007cites this paper
• The influence of hormonal contraceptive use on HIV-1 transmission and disease progression.

  2007cites this paper
• Pregnancy, Hormonal Contraceptive Use, and HIV-Related Death in Rwanda

  2007cites this paper
• Ex Vivo Effect of Estrogen and Progesterone Compared With Dexamethasone on Cell-Mediated Immunity of HIV-Infected and Uninfected Subjects

  2007cites this paper
• Preventing unintended pregnancy and HIV transmission: dual protection or dual dilemma?

  2007cites this paper
• Contraceptive Use among U.S. women with HIV

  2007cites this paper
• Family planning choices for women with HIV.

  2007cites this paper
• Reproduction and fertility in human immunodeficiency virus type-1 infection.

  2007cites this paper
• IgA and Reproductive Tract Immunity

  2007cites this paper
• Behavioral Interventions for Prevention and Control of STDs Among Adolescents

  2007cites this paper
• Immunology of the genital tract - a review

  2007cites this paper
• POPULATION REPORTS 1 Family Planning Choices for Women With HIV Key Points

  2007cites this paper
• Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.

  2007cites this paper
• Network: Hormonal Contraception and HIV

  2007cites this paper
• Genital tract reservoirs

  2006cites this paper
• The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine

  2006influential citation
• HIV Infection and AIDS

  2006cites this paper
• The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women--effects on bleeding patterns, ovarian function and genital shedding of HIV.

  2006cites this paper
• HIV-1 in genital compartments: vexing viral reservoirs

  2006cites this paper
• Use of Hormonal Contraception in Women With Coexisting Medical Conditions

  2006cites this paper
• Factors affecting sexual transmission of HIV-1: current evidence and implications for prevention.

  2005cites this paper
• HIV-1 infected women in Europe.

  2005cites this paper